http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Article/list/47453 For pharmacists, from <em>Drug Topics</em>: News and features for pharmacists about clinical trials, newly approved drugs, and new practices in clinical pharmacy 2009-11-21T07:27:54Z http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Healthcare-Reform-Drug-Topics-readers-speak-out/ArticleStandard/Article/detail/638769?contextCategoryId=47453&ref=25 With the subject of healthcare reform on the front burner in Washington and across the country, Drug Topics invited members of its Frontline editorial advisory board to share their thoughts. A selection of their responses is presented here. 2009-11-03T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/452009/638769/Nov09Cover_195x210_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Rx+Care/Practical-management-of-asthma-CE/CME/Article/detail/639960?contextCategoryId=47453&ref=25 More than 22 million patients in the United States are affected by asthma and collectively were admitted for approximately 444,000 hospitalizations in 2006. With appropriate assessment and treatment by patients and healthcare providers, hospitalizations and deaths from asthma exacerbations can be significantly reduced. This article reviews the role of available asthma medications and provides an overview of the NAEPP's recommendations for management of asthma for patients 12 years of age and older. 2009-11-03T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/452009/639960null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/Metabolic-syndrome-throughout-the-life-cycle-CE/CME/Article/detail/633088?contextCategoryId=47453&ref=25 Prevalence of metabolic syndrome in adults, as well as the increasing prevalence of pediatric obesity, has spurred research into how the condition may affect children and adolescents. Pharmacists should be able to define insulin resistance and metabolic syndrome in children and adults according to national guidelines, list the risk factors associated with metabolic syndrome in children that may increase their risk as adults, describe the role of lifestyle modification in children and adults with metabolic syndrome, and identify the role of medical and surgical treatment for metabolic syndrome and/or obesity. 2009-10-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/412009/633088null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Associations/Supply-of-heparin-further-secured/ArticleStandard/Article/detail/631000?contextCategoryId=47453&ref=25 A second round of revised quality standards for heparin became effective recently, the U.S. Pharmacopeial (USP) Convention has announced. 2009-10-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/402009/631000null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/FDA-issues-guidance-on-REMS/ArticleStandard/Article/detail/630738?contextCategoryId=47453&ref=25 The FDA has announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies. 2009-10-08T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/402009/630738null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Mefloquine-has-a-three-week-half-life/ArticleStandard/Article/detail/632480?contextCategoryId=47453&ref=25 The FDA recently alerted pharmacists to medication error reports about mefloquine (Lariam) prescriptions calling for 250 mg daily rather than the recommended dose of 250 mg weekly for malaria prophylaxis. 2009-10-08T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/412009/632480/FDA-Safety-Page_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Business-Roundtables-Partnership-for-Disaster-Resp/ArticleStandard/Article/detail/630978?contextCategoryId=47453&ref=25 Business Roundtable?s Partnership for Disaster Response today released the findings of its 2009 Flu Season Survey, which provides insights on how companies are preparing for H1N1 Influenza. 2009-10-08T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/402009/630978null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-mandated-REMS-now-in-force-in-pharmaceutical-i/ArticleStandard/Article/detail/632476?contextCategoryId=47453&ref=25 The FDA can require risk evaluation and mitigation strategies for certain prescription drugs and biological products, to ensure that the benefits of such products outweigh the risks. The effect of REMS ripples down through the supply chain to affect how pharmacies dispense medication. 2009-10-08T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/412009/632476null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacists-vital-to-specialty-drug-infusion-cente/ArticleStandard/Article/detail/632487?contextCategoryId=47453&ref=25 Pharmacy should be part of any team evaluating an outpatient center. Effective communication between physicians, hospital administrators, pharmacists, and nursing staff is crucial to whether the infusion center will succeed. 2009-10-08T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/412009/632487null XML http://drugtopics.modernmedicine.com/drugtopics/Top+News/Maryland-pharmacists-receive-H1N1-training-opportu/ArticleStandard/Article/detail/630661?contextCategoryId=47453&ref=25 As the most accessible members of the healthcare team, pharmacists in Maryland are being offered an opportunity to train in preparation for a predicted H1N1 flu pandemic. 2009-10-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/402009/630661null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Roche-addressed-Tamiflu-dosing-discrepancies/ArticleStandard/Article/detail/630387?contextCategoryId=47453&ref=25 Roche Laboratories recently released a statement to healthcare professionals regarding Tamiflu (oseltamivir phosphate) recommendations. Specifically, the company said there have been cases where the units of measure in the instructions on the prescription label have not matched the units of dosing devices. 2009-09-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/402009/630387null HTML http://drugtopics.modernmedicine.com/drugtopics/Top+News/HealthTrans-makes-changes-to-average-wholesale-pri/ArticleStandard/Article/detail/629668?contextCategoryId=47453&ref=25 HealthTrans, a healthcare management solutions company, recently announced changes it made to ensure market readiness for changes to Average Wholesale Prices (AWP). HealthTrans successfully transitioned clients Sept. 16,according to a statement to Drug Topics, and is now effectively processing claims based on Wholesale Acquisition Cost (WAC). 2009-09-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/402009/629668null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Cardinal-Health-expands-services-for-hospital-phar/ArticleStandard/Article/detail/629275?contextCategoryId=47453&ref=25 Cardinal Health is hoping that its newly expanded services offered to hospital pharmacies helps customers to make improvements to their work flow. 2009-09-25T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/392009/629275null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Joint-Commission-targets-safety-failures/ArticleStandard/Article/detail/627559?contextCategoryId=47453&ref=25 The Joint Commission is targeting patient safety failures with a new program that will directly affect pharmacy operations. 2009-09-18T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/382009/627559null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/JD-Power-and-Associates-releases-pharmacy-study/ArticleStandard/Article/detail/627198?contextCategoryId=47453&ref=25 While pharmacy customers with prescription drug coverage are more satisfied with their pharmacy experience, customers with public-private plans are just as satisfied as those with wholly private insurance, according to the J.D. Power and Associates 2009 National Pharmacy Study released today. 2009-09-17T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/382009/627198null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/FDA-advisory-committee-recommends-Cervarix/ArticleStandard/Article/detail/625212?contextCategoryId=47453&ref=25 GlaxoSmithKline has announced that the FDA's Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of Cervarix, the company's candidate cervical cancer vaccine. 2009-09-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/372009/625212null HTML http://drugtopics.modernmedicine.com/drugtopics/Long-Term+Care/Cardiometabolic-disorders-The-pharmacists-role/ArticleStandard/Article/detail/624216?contextCategoryId=47453&ref=25 The term &#34;cardiometabolic disorders&#34; (CMD) refers to a cluster of interrelated risk factors (hypertension, elevated fasting glucose, reduced high-density lipoprotein, elevated triglycerides, and abdominal obesity) that promote the development of atherosclerotic cardiovascular disease and type 2 diabetes. With an estimated 47 million Americans facing increased risk of heart disease because of these conditions, management of patients' CMD is a priority for pharmacists. 2009-09-04T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/362009/624216null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Walgreens-releases-specialty-pharmacy-report/ArticleStandard/Article/detail/624274?contextCategoryId=47453&ref=25 Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more. 2009-09-04T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/362009/624274null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/Overview-of-geriatric-dermatology-CE/CME/Article/detail/624739?contextCategoryId=47453&ref=25 In the practice of geriatric dermatology, pharmacists should be able to explain the physiology of aging skin; describe dermatologic conditions frequently encountered in the elderly, including decubitis ulcers, skin infections, blistering diseases, skin cancers, and melanoma; identify dermatologic manifestations of nutritional deficiency in geriatric patients; and review the role of the pharmacist in managing dermatologic pharmacotherapy. 2009-09-04T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/372009/624739null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Associations/Iowa-board-of-pharmacy-considering-medical-marijua/ArticleStandard/Article/detail/624088?contextCategoryId=47453&ref=25 The Iowa Board of Pharmacy is now one step closer to making its recommendation to the state?s legislature regarding the use of medical marijuana in the state. 2009-09-03T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/362009/624088null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/First-ever-opioid-conversion-text-released/ArticleStandard/Article/detail/622588?contextCategoryId=47453&ref=25 Want to see fear on the face of a pharmacist? Ask for a quick dosage conversion for a 75-year-old woman with breast cancer who has become too weak to swallow MS Contin tablets and needs an oral liquid morphine. Keep reading to learn more about making conversions easier. 2009-08-31T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/362009/622588/OpiodBook_flash.JPG HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Adults-of-45-years-and-younger-are-not-adherent-to/ArticleStandard/Article/detail/622340?contextCategoryId=47453&ref=25 A study released by CVS Caremark found that more than 50 percent of patients under the age of 45 who are prescribed a medication to treat high cholesterol are not optimally adherent to their therapy. 2009-08-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/352009/622340null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-warns-about-stolen-insulin/ArticleStandard/Article/detail/622101?contextCategoryId=47453&ref=25 On Aug. 26 the Food and Drug Administration issued a warning to the public that stolen vials of the long-acting insulin Levemir still may be on the market. 2009-08-27T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/352009/622101null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/NY-pharmacists-voice-concern-over-Medicaid-change/ArticleStandard/Article/detail/620469?contextCategoryId=47453&ref=25 The Pharmacists Society of the State of New York is fighting mad over the state's plan to contract with mail-order pharmacies to deliver high-cost medications to Medicaid customers. 2009-08-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/342009/620469null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-Saphris-to-treat-schizophrenia-and-bi/ArticleStandard/Article/detail/620180?contextCategoryId=47453&ref=25 The U.S. Food and Drug Administration has approved Saphris tablets to treat adults with schizophrenia, and bipolar I disorder in adults. 2009-08-19T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/342009/620180null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/NCPA-launches-student-ambassador-program/ArticleStandard/Article/detail/620192?contextCategoryId=47453&ref=25 The National Community Pharmacists Association (NCPA) has launched its Student Ambassador Program, designed to connect pharmacy students with owners of community pharmacies. 2009-08-19T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/342009/620192null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/FDA-issues-rules-for-investigational-drugs/ArticleStandard/Article/detail/619449?contextCategoryId=47453&ref=25 The U.S. Food and Drug Administration published two rules recently to help clarify how very ill patients can obtain access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and have no other satisfactory treatment options. 2009-08-17T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/342009/619449null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Cardinal-Health-completes-Biotech-acquisition/ArticleStandard/Article/detail/618470?contextCategoryId=47453&ref=25 Cardinal Health has agreed to acquire the assets of privately held Biotech, an operator of Positron Emission Tomography (PET) cyclotrons and nuclear pharmacies in the southwestern United States. 2009-08-12T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/332009/618470null HTML http://drugtopics.modernmedicine.com/drugtopics/Long-Term+Care/Medication-therapy-management-Commercial-programs-/ArticleStandard/Article/detail/617019?contextCategoryId=47453&ref=25 Commercial medication therapy management programs are gaining in strength and popularity for medical, financial, and practical reasons. In Minnesota, a pilot program for state employees was so successful that two years later it expanded into a program for all fully insured members. Another program is in use by Minnesota Medicaid and General Mills. And in North Carolina, the Asheville Project is still going strong. 2009-08-10T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/322009/617019null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/Parkinsons-disease-A-review-CE/CME/Article/detail/617535?contextCategoryId=47453&ref=25 Parkinson's disease usually affects people over the age of 50. About 50,000 Americans are diagnosed with Parkinson's disease each year, with more than half a million Americans affected at any given time. Pharmacists should be able to explain the pathophysiology and clinical presentation of the disease, identify potential complications, discuss current nonpharmacologic therapies and pharmacotherapies, and recommend appropriate treatment strategies. 2009-08-10T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/322009/617535null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Community+Practice/FDA-approves-new-drug-indication-for-Forteo/ArticleStandard/Article/detail/614527?contextCategoryId=47453&ref=25 On July 23, Eli Lilly and Company announced the Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO to treat osteoporosis associated with sustained, systemic glucocorticoid therapy in men and women at high risk of fracture. 2009-07-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/312009/614527null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-approves-vaccines-for-upcoming-flu-season/ArticleStandard/Article/detail/613750?contextCategoryId=47453&ref=25 The U.S. Food and Drug Administration has announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States. 2009-07-24T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302009/613750null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/AACP-session-promotes-humanity-in-pharmacy/ArticleStandard/Article/detail/612461?contextCategoryId=47453&ref=25 Carolyn Brackett, PharmD, Associate Professor of Clinical Pharmacy at Ohio State University?s College of Pharmacy believes it?s possible to bring more humanity and human-to-human interaction to pharmacy ? regardless of the area in which they practice. 2009-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302009/612461null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/FDA-issues-guidance-on-PCIDs/ArticleStandard/Article/detail/610984?contextCategoryId=47453&ref=25 The Food and Drug Administration has issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) used by manufacturers to make drug products more difficult to duplicate by counterfeiters and to make it easier to identify the genuine version of the drug. 2009-07-14T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/292009/610984null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-drug-to-maintain-normal-heart-rhythms/ArticleStandard/Article/detail/608855?contextCategoryId=47453&ref=25 The Food and Drug Administration has approved Multaq 400 mg tablets to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter. 2009-07-06T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282009/608855null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-orders-boxed-warning-for-smoking-cessation-dru/ArticleStandard/Article/detail/608516?contextCategoryId=47453&ref=25 The Food and Drug Administration (FDA) has announced that it is requiring manufacturers to put a boxed warning on the prescribing information for the smoking cessation drugs Chantix and Zyban. 2009-07-02T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272009/608516null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/Drug-eluting-stents-make-a-comeback/ArticleStandard/Article/detail/607928?contextCategoryId=47453&ref=25 Controversy has surrounded the use of drug-eluting stents (DES) since their introduction as a tool of interventional cardiology in 2003. Studies released that year associated DES with increased risk of blood-clotting several years after implantation, and use declined. Since 2007, when the FDA concluded that DES could be appropriate therapy for some patients, intense scrutiny has produced little evidence that DES carry more risk than bare stents do. 2009-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272009/607928null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/CMS-drives-MTM-expansion/ArticleStandard/Article/detail/607937?contextCategoryId=47453&ref=25 Medication therapy management (MTM) programs have been part of prescription drug plans since 2005 after being mandated into law in 2003. MTM gained some muscle when Medicare patients began to enroll in 2006. The 2010 draft Call Letter issued by the Centers for Medicare &amp;amp; Medicaid Services is expected to push the MTM movement even further. 2009-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272009/607937null XML http://drugtopics.modernmedicine.com/drugtopics/Over+the+Counter/Specialty-pharmacy-for-dialysis-patients-opens-in-/ArticleStandard/Article/detail/607940?contextCategoryId=47453&ref=25 A new national retail pharmacy, Fresenius Medical Care Rx, has opened in Nashville. It will provide prescriptions, OTC medications, and diabetic testing supplies through the mail to dialysis patients and will offer them access to pharmacists with specialized training in kidney disease. 2009-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272009/607940null XML http://drugtopics.modernmedicine.com/drugtopics/Medication+Errors/Medication-errors-What-to-do-about-look-alikesound/ArticleStandard/Article/detail/608081?contextCategoryId=47453&ref=25 When the subject of medication errors arises, confusion of drugs with similar names is a real hazard. On written prescriptions, one drug name may be misread as another, and with verbal orders, a drug name may be misheard. Pharmacies are seeking ways to deal with the challenge. 2009-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272009/608081null XML http://drugtopics.modernmedicine.com/drugtopics/Over+the+Counter/Treating-poison-ivy-and-other-summer-nuisances/ArticleStandard/Article/detail/607933?contextCategoryId=47453&ref=25 Perhaps as a byproduct of global warming, poison ivy, oak, and sumac plants are spreading in numbers and their virulence is expanding. Several manufacturers are offering products designed to treat the rash, blisters, and infamous itch of these seasonal irritants. 2009-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272009/607933null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Pharmacy-fights-to-save-Californias-poison-control/ArticleStandard/Article/detail/603304?contextCategoryId=47453&ref=25 Record budget problems have pushed California to eliminate funding for the largest poison control system in the nation. Keep reading to find out about a California pharmacy's fight to keep the poison control system going. 2009-06-12T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242009/603304null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Report-Erectile-dysfunction-drugs-are-similar/ArticleStandard/Article/detail/601507?contextCategoryId=47453&ref=25 A new AHRQ technology assessment and meta analysis of randomized controlled trials concluded that there is not enough evidence to determine which ED drugs are more effective or which may cause fewer and less serious adverse events. 2009-06-03T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/232009/601507null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Pharmacists-can-be-center-of-medical-home/ArticleStandard/Article/detail/601287?contextCategoryId=47453&ref=25 Community pharmacists can and should be the core of disease management programs, according to a recent report by Deloitte Consulting. 2009-06-02T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/232009/601287null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/MTM-means-more-pharmacists-deliver-diabetes-care/ArticleStandard/Article/detail/600552?contextCategoryId=47453&ref=25 Pharmacists are becoming nationally recognized as providers in diabetes care as the growth of medication therapy management programs and changes in Medicare reimbursement have caused many states and private payers to revise their programs. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600552/Diabetes-Program_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/OTC-Fast-relief-for-headaches-and-migraines/ArticleStandard/Article/detail/600557?contextCategoryId=47453&ref=25 In a recent National Headache Foundation survey, 53 percent of respondents had switched from Rx drugs to OTC medications in order to save money. In addition to the old standbys, a few new products are now available. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600557null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/With-specialty-drug-infusion-centers-attention-to-/ArticleStandard/Article/detail/600556?contextCategoryId=47453&ref=25 With many physicians discontinuing delivery of specialty drugs, hospitals must take up the slack. But while access to an outpatient infusion center is of great value to patients, running such a center can be financially hazardous for the provider. Meticulous attention to detail can mean the difference between success and failure. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600556null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Rx-drugs-are-losing-to-generics-in-the-war-for-con/ArticleStandard/Article/detail/600558?contextCategoryId=47453&ref=25 A report from Wolters Kluwer Health has found that in 2008 use of brand-name drugs went down while use of generics soared, representing 60 percent of all prescriptions filled in the United States. The rate of prescription abandonments also went up, in direct correlation to cost of copay. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600558/Money_flash.JPG XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/MedAssist-recruits-pharmacists-for-NC-central-fill/ArticleStandard/Article/detail/600549?contextCategoryId=47453&ref=25 MedAssist, a not-for-profit pharmacy in Mecklenburg, N. C., is using grant monies to create a central fill pharmacy that will eventually serve counties across the state. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600549null XML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Pharmacies-use-incentives-to-attract-new-customers/ArticleStandard/Article/detail/600924?contextCategoryId=47453&ref=25 While retail pharmacies have been offering incentives for years for consumers to switch their prescriptions, many are hoping that new types of coupons may spark life into sales. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/232009/600924null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Shared-insulin-pens-can-transmit-blood-borne-patho/ArticleStandard/Article/detail/600559?contextCategoryId=47453&ref=25 The FDA warns that insulin pens are meant to be used by one patient only. Patients should never share insulin pens, cartridges, or needles. Such sharing may result in transmission of blood-borne pathogens such as HBV, HCV, and HIV. 2009-06-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600559null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Oral-and-IV-drug-coverage-gains-attention/ArticleStandard/Article/detail/600516?contextCategoryId=47453&ref=25 The disparity in coverage between oral and IV drugs/hospital procedures is getting legislative attention at the federal and state level. 2009-05-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/600516null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/2008-Top-200-generic-drugs-by-retail-dollars/ArticleStandard/Article/detail/597086?contextCategoryId=47453&ref=25 Learn more about the 2008 top generic drugs by retail dollars 2009-05-26T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192009/597086null PDF http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/2008-Top-200-branded-drugs-by-total-prescriptions/ArticleStandard/Article/detail/599845?contextCategoryId=47453&ref=25 Learn more about the Top 200 branded drugs by total prescriptions 2009-05-26T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/599845null PDF http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/2008-Top-200-branded-drugs-by-retail-dollars/ArticleStandard/Article/detail/597083?contextCategoryId=47453&ref=25 Find out more about the 200 top branded drugs by retail dollars 2009-05-26T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192009/597083null PDF http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/2008-Top-200-generic-drugs-by-total-prescriptions/ArticleStandard/Article/detail/599844?contextCategoryId=47453&ref=25 Learn more about the top 200 generic drugs by total prescriptions. 2009-05-26T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222009/599844null PDF http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-new-drug-for-enzyme-replacement/ArticleStandard/Article/detail/597108?contextCategoryId=47453&ref=25 The U.S. Food and Drug Administration announced recently the approval of Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods. 2009-05-06T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192009/597108null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Nighttime-pain-relief-is-wide-awake-and-going-stro/ArticleStandard/Article/detail/596641?contextCategoryId=47453&ref=25 In 2009, economic uncertainties, fear of new influenza strains, and pain are contributing to problems with sleeplessness experienced by many among the U.S. population. 2009-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192009/596641null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Infusion-centers-for-specialty-drugs-Hospitals-ste/ArticleStandard/Article/detail/596064?contextCategoryId=47453&ref=25 As rising costs and falling reimbursements cause many physicians to move out of the business of giving specialty-drug infusions, hospitals are taking over the task. 2009-05-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182009/596064null XML http://drugtopics.modernmedicine.com/drugtopics/Long-Term+Care/The-rarest-of-orphan-drugs-find-a-specialty-pharma/ArticleStandard/Article/detail/596067?contextCategoryId=47453&ref=25 Centric Health Resources in St. Louis, Mo., serves patients who have the rarest diseases and need the most expensive drugs. 2009-05-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182009/596067null XML http://drugtopics.modernmedicine.com/drugtopics/Over+the+Counter/New-OTC-products-target-seasonal-allergies/ArticleStandard/Article/detail/596063?contextCategoryId=47453&ref=25 May is National Asthma and Allergy Awareness Month. Several new OTC products are on pharmacy shelves for seasonal sufferers seeking relief. 2009-05-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182009/596063null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Canadian-drugs-for-elderly-fought-by-NY-pharmacist/ArticleStandard/Article/detail/596059?contextCategoryId=47453&ref=25 The New York Senate is considering a bill to permit qualifying seniors to obtain their prescription medications from a Canadian pharmacy group. New York pharmacists oppose any plan to take pharmacy dollars out of the state. 2009-05-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182009/596059null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/At-home-drug-testing-CE/CME/Article/detail/596640?contextCategoryId=47453&ref=25 In order to counsel patients sensitively and appropriately, every pharmacist and pharmacy technician should be knowledgeable about how and when to use at-home drug tests. 2009-05-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/192009/596640null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Associations/Walgreens-moves-ahead-with-POWER-program-in-Florid/ArticleStandard/Article/detail/595592?contextCategoryId=47453&ref=25 Walgreens plans to complete the roll-out of its POWER initiative in its Florida stores by the third quarter of 2009, according to Suzanne Hansen, RPh, MBA, vice president of Walgreens pharmacy services. 2009-04-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182009/595592null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Red-yeast-rice-lowers-cholesterol-but-product-vari/ArticleStandard/Article/detail/592638?contextCategoryId=47453&ref=25 Patients who require lipid-modifying therapy but can't tolerate statins or are unwilling to take statins often try red yeast rice, but they should be aware of extreme variability in the active compounds between products, as well as citrinin, a known nephrotoxin. 2009-04-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152009/592638null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Clopidogrel-boosts-efficacy-of-aspirin-in-preventi/ArticleStandard/Article/detail/592640?contextCategoryId=47453&ref=25 Clopidogrel with aspirin is a better option than aspirin alone for patients with atrial fibrillation (AF) who are deemed unsuitable for warfarin or are unwilling to take it, according to data presented at the recent 58th Annual Scientific Session of the American College of Cardiology in Orlando, Fla. 2009-04-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152009/592640null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Biologic-agents-Their-long-term-safety/ArticleStandard/Article/detail/591693?contextCategoryId=47453&ref=25 For treatment of many diseases, use of biologic agents continues to grow. In assessment of risk, however, clinical trials may not yield sufficient information. 2009-04-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142009/591693null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/FDA-Rx-labeling-clarified/ArticleStandard/Article/detail/591689?contextCategoryId=47453&ref=25 Widespread confusion about the new label format for prescription drugs has sent FDA officials to association meetings around the country, explanations in hand. 2009-04-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142009/591689null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Feature+Articles/Pain-management-CE/CME/Article/detail/592682?contextCategoryId=47453&ref=25 Upon completion of this activity, pharmacists should be able to educate other healthcare providers and patients about the nature of pain and the importance of its adequate treatment; recommend appropriate drug therapies for different types of pain; and counsel patients and providers on the difference between addiction, physical dependence, tolerance, and pseudoaddiction. 2009-04-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/152009/592682null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Medication-errors-can-be-reduced-by-patient-counse/ArticleStandard/Article/detail/591690?contextCategoryId=47453&ref=25 Students in a University of Florida healthcare risk management class examine the connection between medication errors and patient counseling from the dual perspective of pharmacists and risk managers. 2009-04-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142009/591690null XML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Pfizer-returning-ED-device-to-pharmacies/ArticleStandard/Article/detail/590119?contextCategoryId=47453&ref=25 The Caverject Impulse Dual Chamber System, a drug delivery device used to treat erectile dysfunction that was withdrawn by the manufacturer, will return to pharmacy shelves, according to Pfizer, Inc. 2009-03-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142009/590119null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/GlaxoSmithKline-to-share-knowledge-profits/ArticleStandard/Article/detail/589544?contextCategoryId=47453&ref=25 GlaxoSmithKline (GSK) plans share more than 800 drug patents with others trying to discover new cures for neglected tropical diseases. Keep reading to learn more. 2009-03-26T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/132009/589544null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/CPI-releases-new-concerns-about-Pfizers-Celebrex-s/ArticleStandard/Article/detail/588986?contextCategoryId=47453&ref=25 The Center for Public Integrity (CPI) has called into question the ethics and necessity of the Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen study (PRECISION), sponsored by Pfizer and run by Steven Nissen, MD, with the Cleveland Clinic. 2009-03-24T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/132009/588986null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Wyeth-liability-case-advances-in-California/ArticleStandard/Article/detail/588139?contextCategoryId=47453&ref=25 California may be moving toward a new form of liability. The state Supreme Court declined to hear an appeal from Wyeth in a case the held the drug maker liable for injuries caused by generic versions of Reglan (metoclopramide) made by another manufacturer. 2009-03-19T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/122009/588139null HTML http://drugtopics.modernmedicine.com/drugtopics/Associations/Biotech-generics-bill-introduced-in-Congress/ArticleStandard/Article/detail/587490?contextCategoryId=47453&ref=25 A bipartisan bill that would allow the U.S. Food and Drug Administration (FDA) to approve affordable copies of biotech drugs has been introduced in Congress. 2009-03-16T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/122009/587490null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Pfizer-to-sell-more-generics/ArticleStandard/Article/detail/585782?contextCategoryId=47453&ref=25 Pfizer Inc. will begin selling dozens more generic drugs through new deals with an Indian generic company, becoming the latest brand-name drug maker looking to grow its market share in the growing generics market. 2009-03-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112009/585782null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Study-Pharmacists-most-likely-to-catch-medication-/ArticleStandard/Article/detail/585783?contextCategoryId=47453&ref=25 Most medication errors in primary care practices are prescribing errors and, while a majority of those reach the patient, pharmacists are most likely to intercept the mistakes, according to a new study by the Agency for Healthcare Research and Quality. 2009-03-09T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112009/585783null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-Toviaz-for-treatment-of-overactive-bl/ArticleStandard/Article/detail/585671?contextCategoryId=47453&ref=25 Toviaz extended-release tablets win FDA approval for treatment of overactive bladder 2009-03-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102009/585671null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Sleep-disorder-drugs-require-patient-counseling/ArticleStandard/Article/detail/585680?contextCategoryId=47453&ref=25 Medications for sleep disorders may cause patients to sleepwalk, drive, eat, even have sex while asleep. Patients don't often ask for information about sleep medications, so pharmacists must offer it. 2009-03-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102009/585680null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Lamictal-starter-kits-Avoiding-medication-errors/ArticleStandard/Article/detail/585683?contextCategoryId=47453&ref=25 Confusion about the three different lamictal starter kits can lead to pharmacy and patient error. There are several things pharmacists can do to ensure that patients use their kits properly. 2009-03-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102009/585683null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Vaccination-by-pharmacists-New-York-pharmacists-tr/ArticleStandard/Article/detail/585670?contextCategoryId=47453&ref=25 New York phamacists train to administer vaccinations for flu and pneumonia 2009-03-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102009/585670null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Vaccination-by-pharmacists-Arizonas-list-of-permis/ArticleStandard/Article/detail/585669?contextCategoryId=47453&ref=25 Arizona proposal would expand list of vaccines given by pharmacists 2009-03-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102009/585669null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Waxman-talk-highlight-of-GPhA-meeting/ArticleStandard/Article/detail/583879?contextCategoryId=47453&ref=25 Henry Waxman this week told attendees of the Generic Pharmaceutical Association Annual in Florida that he would work to pass legislation that would allow generic versions of biogenerics and biosimilar pharmaceuticals. 2009-02-27T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092009/583879null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Video-Pediatric-pharmacy-fills-a-niche/ArticleStandard/Article/detail/582589?contextCategoryId=47453&ref=25 There are more than 50 million children in the US, most of whom receive some sort of medication during their childhood. That may be one reason niche pharmacies are becoming more popular. 2009-02-19T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082009/582589/Young-Girl_flash.JPG HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Off-label-drugs-prescribed-without-clinical-eviden/ArticleStandard/Article/detail/578172?contextCategoryId=47453&ref=25 Medications are often prescribed for off-label purposes without evidence of effectiveness or safety. Unsupported use is especially high for antidepressants, antipsychotics, and sedatives. 2009-02-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/052009/578172/DrugPills_flash.JPG XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pain-Care-Act-goes-to-the-House-one-more-time/ArticleStandard/Article/detail/578170?contextCategoryId=47453&ref=25 Versions of the Pain Care Act have been introduced in Congress every year since 2003. Passed in the House of Representatives in 2008, it must pass there again before moving to the Senate. 2009-02-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/052009/578170null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Kentucky-free-pharmacy-serves-low-income-patients/ArticleStandard/Article/detail/578177?contextCategoryId=47453&ref=25 Volunteer pharmacists help a free pharmacy in rural Kentucky serve low-income patients. 2009-02-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/052009/578177/VolunteerPharmacy_flash.JPG XML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/Eli-Lilly-to-pay-more-than-800-million-for-off-lab/ArticleStandard/Article/detail/576282?contextCategoryId=47453&ref=25 Eli Lilly and Co. has agreed to plead guilty to one misdemeanor violation of the Food, Drug, and Cosmetic Act and will pay more approximately $800 million for unproven marketing and promotional claims involving the antipsychotic medication Zyprexa. 2009-01-20T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042009/576282null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Clinical-pharmacists-make-economic-sense/ArticleStandard/Article/detail/576191?contextCategoryId=47453&ref=25 Clinical pharmacy services can significantly help curb prescription drug spending and other healthcare costs, according to a new study. 2009-01-19T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042009/576191null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Sizzling-sun-care-category-led-by-technology-and-c/ArticleStandard/Article/detail/574186?contextCategoryId=47453&ref=25 Sun care is a hot category that continues to grow. Regardless of seasonality in most parts of the country and many years of flat sales, this category has come back strong in the last few years thanks to new technology, specialized products, and an overall greater consumer awareness of the sun's dangerous effects. 2009-01-07T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/022009/574186null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/IV-drug-errors-highlight-need-for-universal-standa/ArticleStandard/Article/detail/574345?contextCategoryId=47453&ref=25 The annual summit of the American Society of Health-System Pharmacists called for ways to reduce drug errors. The need for universal IV concentrations is primary. &#34;Safety will improve dramatically if we all work with the same tools.&#34; (Peter Angood, Joint Commission) 2009-01-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/022009/574345null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pricier-heparin-proves-better-for-patients/ArticleStandard/Article/detail/574343?contextCategoryId=47453&ref=25 A new study shows that more expensive heparin reduces patient costs. 2009-01-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/022009/574343/OfficeStudy_flash.JPG XML http://drugtopics.modernmedicine.com/drugtopics/CME+Showcase/Community-acquired-MRSA-infections-CE/CME/Article/detail/579864?contextCategoryId=47453&ref=25 After participating in this activity, pharmacists should be able to distinguish between CA-MRSA and HA-MRSA, recommend outpatient and inpatient treatment options, and identify prevention methods. 2009-01-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/062009/579864null REMOTE http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Drug-Pipeline-What-to-watch-in-2009/ArticleStandard/Article/detail/574352?contextCategoryId=47453&ref=25 A look at emerging medications and treatments likely to receive notice in 2009. 2009-01-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/022009/574352null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Premixed-conivaptan-is-now-available-from-Astellas/ArticleStandard/Article/detail/574344?contextCategoryId=47453&ref=25 Conivaptan (Vaprisol) is now available in premixed single-use formulations. 2009-01-01T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/022009/574344null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/UCSF-investigators-Drug-companies-distort-trial-in/ArticleStandard/Article/detail/572096?contextCategoryId=47453&ref=25 A team of medical investigators at the University of California, San Francisco, has accused drug companies of bias by distorting the results of their trials in medical journals, which many doctors rely on to determine whether to prescribe new drugs. 2008-12-17T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/512008/572096null HTML http://drugtopics.modernmedicine.com/drugtopics/FDA/FDA-investigating-asthma-medications/ArticleStandard/Article/detail/572093?contextCategoryId=47453&ref=25 The U.S Food and Drug Administration is investigating whether some asthma medications, in rare cases, can increase the risk of serious asthma complications. 2008-12-17T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/512008/572093/Pharmacists-Duty-to-Warn_flash.jpg HTML http://drugtopics.modernmedicine.com/drugtopics/Community+Practice/C-difficile-kills-more-patients-every-year/ArticleStandard/Article/detail/569586?contextCategoryId=47453&ref=25 Deaths from C. difficile increase yearly 2008-12-15T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/492008/569586null XML http://drugtopics.modernmedicine.com/drugtopics/Neurology/Gamunex-wins-orphan-drug-approval-from-FDA-for-tre/ArticleStandard/Article/detail/569596?contextCategoryId=47453&ref=25 FDA approves Gamunex for treatment of neurologic disease. 2008-12-15T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/492008/569596null XML http://drugtopics.modernmedicine.com/drugtopics/Pharmacy+News/Drug-Topics-360-Network/ArticleStandard/Article/detail/570976?contextCategoryId=47453&ref=25 Drug Topics 360 Network 2008-12-07T05:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/502008/570976null HTML